Health ❯Healthcare ❯Biotechnology

Gene Therapy

Hemophilia A Bluebird Bio Market Trends

First Death Reported from Sarepta's Duchenne Gene Therapy Raises Safety Concerns

Pfizer Ends Hemophilia Gene Therapy Partnership With Sangamo, Sending Stock Plummeting